- Home
- CRDL vs USGO Comparison
CRDL vs USGO Comparison
Compare CRDL & USGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- USGO
- Stock Information
- Founded
- CRDL 2017
- USGO 2015
- Country
- CRDL Canada
- USGO United States
- Employees
- CRDL N/A
- USGO N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- USGO Precious Metals
- Sector
- CRDL Health Care
- USGO Basic Materials
- Exchange
- CRDL Nasdaq
- USGO Nasdaq
- Market Cap
- CRDL 112.4M
- USGO 117.3M
- IPO Year
- CRDL N/A
- USGO 2023
- Fundamental
- Price
- CRDL $1.44
- USGO $8.29
- Analyst Decision
- CRDL Strong Buy
- USGO Strong Buy
- Analyst Count
- CRDL 2
- USGO 1
- Target Price
- CRDL $9.00
- USGO $26.50
- AVG Volume (30 Days)
- CRDL 289.4K
- USGO 39.4K
- Earning Date
- CRDL 08-11-2025
- USGO 08-12-2025
- Dividend Yield
- CRDL N/A
- USGO N/A
- EPS Growth
- CRDL N/A
- USGO N/A
- EPS
- CRDL N/A
- USGO N/A
- Revenue
- CRDL N/A
- USGO N/A
- Revenue This Year
- CRDL N/A
- USGO N/A
- Revenue Next Year
- CRDL N/A
- USGO N/A
- P/E Ratio
- CRDL N/A
- USGO N/A
- Revenue Growth
- CRDL N/A
- USGO N/A
- 52 Week Low
- CRDL $0.77
- USGO $5.00
- 52 Week High
- CRDL $2.63
- USGO $14.46
- Technical
- Relative Strength Index (RSI)
- CRDL 56.90
- USGO 42.03
- Support Level
- CRDL $1.14
- USGO $8.69
- Resistance Level
- CRDL $1.42
- USGO $9.11
- Average True Range (ATR)
- CRDL 0.10
- USGO 0.44
- MACD
- CRDL 0.01
- USGO 0.04
- Stochastic Oscillator
- CRDL 83.33
- USGO 48.88
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's main product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About USGO U.S. GoldMining Inc. Common stock
US Goldmining Inc is a mineral exploration and development company. It is focused on the exploration and development of a project located in Alaska, USA. The company's sole property is Whistler Project which is a gold-copper exploration project located in the Yentna Mining District, approximately 170 km northwest of Anchorage, Alaska.